Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for multiple myeloma. - Mersi J; Burow L; Zhou X; Eisele F; Fante M; Riedhammer C; Stich A; Isberner N; Afrin N; Duell J; Topp MS; Einsele H; et al. (Blood advances, 2026)